In the article “Olfactory copy number association with age at onset of Alzheimer disease” by C.A. Shaw et al. (Neurology® 2011;76:1302-1309), there is an error in the disclosure. Dr. Doody “… [receives] research support from Medivation Inc. and Sonexa Therapeutics, Inc.” should have read Dr. Doody “… holds stock options in Medivation Inc. and Sonexa Therapeutics, Inc.” The editorial staff regrets the error.
